Reconstituting lyophilised peptides: solvent, concentration and stability in the lab

Research-use notice: this article is for legitimate laboratory and educational research only. It does not provide guidance for human use, administration, dosing or treatment.

Reconstitution is the step where most avoidable error enters a peptide experiment, and the literature on it is older and better than most people assume. A lyophilised research peptide is a dry salt of unknown water content in a vial whose label mass is not the peptide mass. Turning it into a stock of known concentration means choosing a solvent to suit the sequence, calculating from net peptide content rather than the gross figure, dissolving without foaming, and storing the result so as to limit oxidation, deamidation, adsorption and freeze–thaw damage. This article sets out that laboratory method for preparing an assay stock, with a source behind each step. It says nothing about use in people.

Why peptides are supplied lyophilised

Synthetic peptides are shipped freeze-dried because peptide bonds and side chains are more stable without water. In solution a peptide faces hydrolysis, deamidation, oxidation and aggregation at rates set by pH, temperature and dissolved oxygen; dry, those reactions slow by orders of magnitude. Wang’s 2000 review in the International Journal of Pharmaceutics covers both the benefits of freeze-drying and the stresses it imposes, including the residual moisture the cake retains. That cake is not pure peptide by weight: it is a salt, usually a trifluoroacetate (TFA) or acetate, carrying bound water, as our article Lyophilised peptides explained sets out. The peptide fraction, the net peptide content (NPC), is typically 70–90% and is stated, if at all, on the batch laboratory report.

Step 1: record before you open the vial

Before any solvent is added, write down the product name, the lot number from the vial label, the net peptide content, HPLC purity and salt form from the batch report, and the date. Note it if NPC is absent, because that changes how the concentration can be expressed (Step 3). This record is the start of the preparation log in Step 6, and the only way to trace an odd result back to a particular vial months later.

Step 2: choose the solvent by sequence

Supplier solubility guidance is broadly consistent: start from the sequence, estimate net charge and hydrophobicity, and pick the gentlest solvent that will work. GenScript’s technical note sets out the net-charge method: assign −1 to each acidic residue (Asp, Glu and the C-terminal carboxyl), +1 to each basic residue (Lys, Arg, His and the N-terminal amine), and sum. Merck’s guidelines and Bachem’s dissolution FAQ give the same decision tree.

Two rules follow. Use the smallest volume of the strongest solvent first and dilute afterwards, because adding water to a half-dissolved hydrophobic peptide can precipitate it irreversibly. And test a small portion first where the vial contents allow. Bachem notes that gentle warming or short sonication “is usually tolerated”; neither should be used on a Cys- or Met-containing peptide without checking stability.

What bacteriostatic water is, and when it is the wrong solvent

Bacteriostatic water is sterile water with benzyl alcohol added as a preservative. The Pfizer prescribing information specifies “0.9% (9 mg/mL) or 1.1% (11 mg/mL) of benzyl alcohol added as a bacteriostatic preservative”, gives the pH as 5.7 (4.5 to 7.0), and describes a container “from which repeated withdrawals may be made”. That last phrase is why it appears in laboratory work: a stock sampled repeatedly over days or weeks meets air each time, and the preservative limits bacterial growth in between. Plain sterile water offers no such protection, so a plain-water stock is better frozen in single-use aliquots.

Benzyl alcohol is not inert, and there are two situations in which it is the wrong solvent for an assay stock.

• Cell culture and other live-cell assays. Chang and colleagues (Experimental Eye Research, 2008) measured benzyl alcohol cytotoxicity in retinal pigment epithelial cells and reported it to be concentration- and time-dependent, with clear toxicity at the 9 mg/mL present in preserved water. A stock made up in bacteriostatic water and diluted 1:100 into culture medium still carries 90–110 µg/mL benzyl alcohol. For cell work, reconstitute in sterile water or buffer and filter-sterilise if the assay needs it.
• Analytical work. Benzyl alcohol is a small aromatic alcohol, so it absorbs in the ultraviolet region used to quantify peptides and is retained on reversed-phase columns. For a UV or HPLC concentration check, reconstitute in plain water or the mobile-phase diluent instead.

The same label carries a prominent “not for use in neonates” warning. That is a reminder that the preservative is an added ingredient, not a neutral solvent: declare it in the preparation record and account for it in any assay the stock reaches.

Step 3: calculate concentration from net peptide content

The number on the vial label is the gross mass of lyophilised powder, or the nominal fill. It is not the mass of peptide; the difference is counterion and water. A TFA salt of a peptide with several basic residues can be 15–25% TFA by mass, and the cake holds several percent water; our article on peptide counterions and TFA works through the mass balance. Cornish and colleagues showed in 1999 that TFA carried over from purified proteins inhibited proliferation of cultured osteoblasts and chondrocytes: a second reason to know the salt form, not just the peptide mass.

Use the net peptide content from the batch report; if it is not stated, the recorded concentration is nominal and comparison across batches is approximate. A worked example for an assay stock:

Had the calculation used the 5.0 mg label mass, the stock would have been recorded as 1,250 µM, an overstatement of 22%. The error is silent: the solution looks identical, and it shows up only as a shifted EC₅₀ or as disagreement between batches with different salt loads. Some laboratories also correct for HPLC purity (× 0.985 for a 98.5% batch); state whether you do, because purity is a chromatogram area percentage, not a mass fraction. See What does 99% purity actually mean?

Step 4: dissolution technique

Let the vial reach room temperature before opening it, so condensation does not form on the cold cake. Add the measured solvent slowly down the inside wall rather than onto the powder, then swirl or roll gently; do not shake, vortex at speed or invert repeatedly. Peptides concentrate at the air–water interface, and foam exposes a large interfacial area where aggregation nucleates. Zapadka and colleagues’ 2017 review in Interface Focus surveys the factors that affect the physical stability of peptides in solution; our article on peptide aggregation and assay variability explains why aggregate in a stock becomes noise in a bioassay.

Give the cake a few minutes to hydrate, then check clarity against a dark background. Haze, visible particles or a film at the meniscus means incomplete dissolution or aggregation; do not aliquot until the cause is understood, and do not top up with solvent unless you recalculate and record the new concentration.

Low-bind labware

Peptides adsorb to surfaces, and for a dilute stock the loss can be large. Goebel-Stengel and colleagues (Analytical Biochemistry, 2011) tracked eight radiolabelled peptides across glass, polystyrene, polypropylene and polyallomer tubes and found tube material alone moved recovery widely: insulin came back at 10.9% from polypropylene against 68.3% from polyallomer. Kristensen, Henriksen and Andresen (PLOS ONE, 2015) showed that for cationic peptides the loss grows as concentration falls, recovering only 10–20% of a 1 µM peptide from standard glass and polypropylene while low-binding tubes did better. The problem is therefore worst in the dilute working solutions an assay actually uses. Use low-binding tubes and tips for every transfer, keep transfers few, and hold dilute solutions no longer than necessary. Our guide to peptide adsorption and sample recovery covers the materials.

Step 5: aliquot and freeze–thaw

Once the stock is clear, divide it immediately into single-use volumes in labelled low-bind tubes and freeze. Every freeze–thaw cycle concentrates solutes at the ice front, shifts local pH as buffer components crystallise unevenly and gives the peptide another interface to adsorb to, so cycling one tube repeatedly compounds all three problems above. Size aliquots to the experiment and discard any thawed remainder. Store at −20 °C for weeks or −80 °C for longer, protected from light. A preserved stock sampled repeatedly should be refrigerated between samplings and given a discard date; the preservative limits microbial growth but does nothing for chemical stability.

Stability in solution

Two chemical pathways account for most degradation of peptides in aqueous solution, and both depend on pH.

Oxidation of cysteine and methionine

Methionine oxidises to methionine sulfoxide and, under harsher conditions, the sulfone; free cysteine thiols oxidise to disulfides, forming dimers or scrambled bridges. Cleland, Powell and Shire’s 1993 review of protein formulation stability treats aggregation, deamidation and oxidation together and sets out the variables behind them. In practice: degas the solvent for Cys- and Met-containing sequences, as Bachem advises; minimise headspace in aliquot tubes; avoid DMSO for these peptides, which Merck calls unstable in it; and protect from light. Methionine oxidation shows as a +16 Da species by LC–MS; see peptide oxidation: methionine and LC–MS analysis.

Deamidation of asparagine and glutamine

Asparagine, and more slowly glutamine, lose their side-chain amide through a cyclic succinimide intermediate that opens to a mixture of aspartate and isoaspartate. Patel and Borchardt established the kinetics in 1990 in the model hexapeptide Val-Tyr-Pro-Asn-Gly-Ala: between pH 5 and 12 it deamidated exclusively by the cyclic imide route, while at acidic pH the side-chain amide was hydrolysed directly, giving aspartate only. They reported a “marked dependence on pH, temperature, and buffer composition”, and a companion paper the same year showed that the residue following the Asn sets the rate at neutral to alkaline pH. An Asn in a labile sequence context is therefore least stable warm and near neutral, and much more stable cold and mildly acidic. See deamidation and isoaspartate analysis.

pH measurement and buffering

Unbuffered water gives no control over pH, and a TFA-salt peptide in pure water typically sits at pH 3–5 from its own counterion: favourable for storage, but not the assay pH. Measure the stock pH with a calibrated micro-electrode or pH paper, record it, and bring the solution to assay pH only at the point of use. If a buffered stock is unavoidable, use a low-concentration buffer at pH 4–6 and record it: Patel and Borchardt observed buffer catalysis of deamidation between pH 7 and 11, so for an Asn-rich sequence the buffer species and its concentration are variables, not neutral background.

Filtration

If the assay needs a sterile or particle-free stock and the peptide was not reconstituted in a sterile diluent, filter through a 0.22 µm membrane. Membrane choice matters: Sartorius’ application note on protein recovery found cellulose acetate and polyethersulfone (PES) membranes adsorbed on average less than 5% of the protein, while nylon and PVDF adsorbed more than 30% under the same conditions, and adsorption also varied with sample pH. Use a low-binding PES membrane, pre-wet it, discard the first drops, and if recovery matters check the concentration afterwards by UV absorbance or HPLC.

Step 6: document the preparation

A reconstitution that is not recorded cannot be repeated, and an assay built on it cannot be troubleshot. Add to the Step 1 record: solvent, volume and any preservative or co-solvent; the concentration in mg/mL and µM with the molecular weight used; measured pH, appearance and whether it was filtered; and the date, operator, aliquot size and storage location. Put the essentials on each tube: name, concentration, date, solvent. A tube labelled only with a peptide name is a tube of unknown concentration.

How to check a peptide batch before reconstituting it

Everything above depends on the batch report. Before dissolving a vial, check:

• The batch number on the report matches the vial label.
• Identity is confirmed by mass spectrometry; the observed mass for the free peptide is the molecular weight for the molar calculation.
• Purity is given as an HPLC area percentage with the method stated, so you read it as a separation result rather than a content figure.
• Net peptide content and salt form are stated, or you note their absence and treat the concentration as nominal.
• Method, date and report reference are present so the report can be verified with the laboratory.

Any Thistle batch can be checked on our batch report lookup. For the method, see How to read a peptide COA and What does 99% purity actually mean?

For a research stock that will be sampled repeatedly, Thistle supplies Bacteriostatic Water — 10ml Research Diluent at £7.99 and Bacteriostatic Water — 3ml Research Diluent at £3.99. For cell-based assays, use a preservative-free sterile diluent as explained above.

Are research peptides and bacteriostatic water legal in the UK?

Research peptides supplied by Thistle have no UK marketing authorisation as medicines and are not controlled drugs under the Misuse of Drugs Act 1971. They, and the bacteriostatic water sold alongside them, are research materials for laboratory use. Presentation matters: in April 2026 the MHRA said that where clinics make medicinal claims for peptide injections, those products will be treated as medicines under the Human Medicines Regulations 2012. That is why this article describes a laboratory method and makes no claims about treating, preventing or improving any condition.

This section is general information, not legal advice.

Storage and handling

Keep lyophilised vials sealed, dry and protected from heat and light until the day of reconstitution, and follow the vial label and batch documentation. In solution, aliquot and freeze as in Step 5. See our peptide storage guide.

Reconstitution FAQs

Can I use bacteriostatic water for cell culture experiments?

Not as the stock diluent. The 2008 Chang study found benzyl alcohol cytotoxic to retinal pigment epithelial cells at the 9 mg/mL present in preserved water, and a 1:100 dilution of such a stock still leaves 90–110 µg/mL in the medium. Use sterile water or buffer and filter-sterilise if the assay needs it.

Why does my calculated concentration differ from the vial label?

Because the label mass includes counterion and water. At 82% net peptide content, a stock calculated from the label is overstated by about 22%. Calculate from NPC where it is stated.

How long is a reconstituted peptide stable?

It depends on sequence, pH and temperature. An Asn in a labile sequence context is least stable near neutral pH at room temperature; Cys and Met oxidise in air-saturated solution. Frozen single-use aliquots are the only general answer.

Should I filter the stock?

Only if the assay needs it. Nylon and PVDF membranes adsorbed more than 30% of the protein in the Sartorius tests; cellulose acetate and PES stayed under 5%. Pre-wet, discard the first drops and check the concentration afterwards.

How much does bacteriostatic water cost in the UK?

Prices vary by supplier. At the time of writing, Thistle sells Bacteriostatic Water 10ml at £7.99 and Bacteriostatic Water 3ml at £3.99. Both are supplied as research diluents.

Sources

• Bachem. How to dissolve a peptide. Technical FAQ. Solvent choice by composition; DMSO caution for Cys, especially as trifluoroacetates; degassed buffers for Cys and Met; sonication and warming.
• GenScript. Peptide solubility guidelines. Technical note. Net-charge method; water, ammonium hydroxide, acetic acid, organic solvents; no ammonium hydroxide with Cys.
• Merck (Sigma-Aldrich). Solubility guidelines for peptides. Technical article. 0.1 M ammonium bicarbonate for acidic peptides, 25% acetic acid for basic, ACN/DMSO/DMF for hydrophobic; Cys and Met unstable in DMSO.
• Wang W. Lyophilization and development of solid protein pharmaceuticals. International Journal of Pharmaceutics. 2000;203(1–2):1–60. Why freeze-drying is used and the stresses it imposes.
• Pfizer. Bacteriostatic Water for Injection, USP: prescribing information. 0.9% (9 mg/mL) or 1.1% (11 mg/mL) benzyl alcohol; pH 5.7 (4.5–7.0); repeated withdrawals; not for use in neonates.
• Chang YS, Wu CL, Tseng SH, Kuo PY, Tseng SY. In vitro benzyl alcohol cytotoxicity: implications for intravitreal use of triamcinolone acetonide. Experimental Eye Research. 2008;86(6):942–950. Concentration- and time-dependent toxicity in retinal pigment epithelial cells.
• Cornish J, Callon KE, Lin CQ, et al. Trifluoroacetate, a contaminant in purified proteins, inhibits proliferation of osteoblasts and chondrocytes. American Journal of Physiology – Endocrinology and Metabolism. 1999;277(5):E779–E783.
• Goebel-Stengel M, Stengel A, Taché Y, Reeve JR Jr. The importance of using the optimal plasticware and glassware in studies involving peptides. Analytical Biochemistry. 2011;414(1):38–46. Eight radiolabelled peptides across glass, polystyrene, polypropylene and polyallomer.
• Kristensen K, Henriksen JR, Andresen TL. Adsorption of cationic peptides to solid surfaces of glass and plastic. PLOS ONE. 2015;10(5):e0122419. 10–20% recovery at 1 µM; loss falls as concentration rises.
• Zapadka KL, Becher FJ, Gomes dos Santos AL, Jackson SE. Factors affecting the physical stability (aggregation) of peptide therapeutics. Interface Focus. 2017;7(6):20170030.
• Patel K, Borchardt RT. Chemical pathways of peptide degradation. II. Kinetics of deamidation of an asparaginyl residue in a model hexapeptide. Pharmaceutical Research. 1990;7(7):703–711, and III. Effect of primary sequence on the pathways of deamidation of asparaginyl residues in hexapeptides. 1990;7(8):787–793. Cyclic imide route at pH 5–12, direct hydrolysis at acidic pH, buffer catalysis at pH 7–11, and the sequence dependence.
• Cleland JL, Powell MF, Shire SJ. The development of stable protein formulations: a close look at protein aggregation, deamidation, and oxidation. Critical Reviews in Therapeutic Drug Carrier Systems. 1993;10(4):307–377.
• Sartorius. How to increase recovery at critical protein samples: impact of syringe filter membrane, volume and pH. Application note. Cellulose acetate and PES under 5% adsorption; nylon and PVDF over 30%.
• Aesthetics Journal. MHRA investigates clinics following peptide claims. 15 April 2026.

Published by Thistle BioLabs, a UK supplier of research materials. This article summarises external research, not studies conducted by Thistle. Educational information only; no medical advice or recommendation for personal use.